ViaCord supports Phase 1 Clinical Trial with Duke University Medical center to study safety of cord blood infusion in children with Autism.
According to the Centers for Disease Control and Prevention (CDC), the number of U.S. children with Autism Spectrum Disorder (ASD) has sharply increased to 1 in 68 – up 30% from two years ago when the CDC estimated that 1 in 88 children had the disorder. The data also showed that ASD is almost five times more common among boys than girls:
1 in 42 boys versus 1 in 189 girls.1
ASD is a group of disorders characterized by “persistent deficits in social communication and social interaction across multiple contexts and restricted, repetitive patterns of behavior, interests, or activities.” Although the exact causes of ASD are still unknown, research suggests that both genes and environment play important roles. 2